Druggists lobby seeks ban on online sales;opposes govt portal

Image
Press Trust of India Mumbai
Last Updated : May 03 2017 | 9:42 PM IST
The All-India Organisation of Chemists and Druggists (AIOCD) today reiterated their demand for a total ban on online sales of drugs and opposed the government plan to set up new e-portal to check antimicrobial resistance and substandard drugs.
The Union health ministry is planning to set up an portal to regulate and plug the gaps in drug sales through all platforms, including e-pharmacies to ensure availability of right drugs that meet the quality standards, and also to curb anti-microbial resistance drugs apart from regulating online drug sales.
According to the proposal, an autonomous body will be set up to develop and maintain the e-platform on which drug- makers, stockists, wholesalers, distributors, licenced chemists and e-pharmacies have to register.
One of the chief concerns for the ministry is the rising sale of sub-standard drugs, about which complaints continue to pour in. A recent survey published by the government showed that about 3 per cent of all the drugs sold in the country are substandard.
"The proposal of e-portal by the Union health ministry is completely impractical. Considering the insufficient IT infrastructure in the country, it will be difficult and difficult for most of stockists, druggists and chemists to upload the details of the sale on the e-portal within a stipulated time. We fear that this will cause drug scarcity," Jagannath Shinde, president of AIOCD said in a statement.
The association that claims to represent over 8 lakh chemists and druggists, has also cautioned the ministry that online sale of medicine if allowed, will prove hazardous to public health as unscrupulous elements can route spurious drugs to customers via online platform.
"Not only those doctors registered with the Medical Council of India or their respective state medical/dental councils, but also those doctors from homoeopathy, ayurveda and
unani indulge in allopathic practises and issue prescriptions.
"This is a serious problem and if the medicines are denied on such prescriptions, people in the rural areas will be deprived of medicines which can even lead to a law and order issue," Shinde warned.
Noting that lax regulatory mechanism is the real problem, he pointed out that drug sales are already monitored by the food and drugs administration in states.

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: May 03 2017 | 9:42 PM IST

Next Story